5 Recruiting AL Amyloidosis Phase 2 Clinical Trials

Active phase 2 studies for al amyloidosis enrolling across the USA. Verify eligibility and contact site coordinators.

All AL Amyloidosis studies

Phase 2 Studies for AL Amyloidosis

🔵 Active, Not Recruiting Phase2

Ixazomib Maintenance Study in Patients With AL Amyloidosis

📍 Tufts Medical Center — Boston, Massachusetts

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

📍 Boston Medical Center — Boston, Massachusetts

View Study & Checklist ➔

🟢 Recruiting Phase2

Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial

📍 Mayo Clinic in Arizona — Scottsdale, Arizona

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis

📍 Yale University — New Haven, Connecticut

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

📍 Vanderbilt Ingram Cancer Center — Nashville, Tennessee

View Study & Checklist ➔